NIH staff revolt, new analysis affirm the critical role and vulnerability of US academic science
Editor's Note Several hundred National Institutes of Health (NIH) employees have issued a rare internal rebuke of the agency’s current leadership under Director Jay Bhattacharya, STAT June 9 reports. The open letter, dubbed the “Bethesda Declaration,” criticizes abrupt Trump-era policy changes, including the cancellation of health equity and LGBTQ+ research,…
High drug manufacturing costs threaten hospital-led pharmacy expansion
Editor's Note Hospitals are ramping up in-house pharmacy operations to boost revenue and improve care, but high US manufacturing costs continue to stall a broader federal effort to reshore drug production, Modern Healthcare June 5 reports. As detailed in the article, an aging, medically complex population is driving demand for…
Feds take action on Hurricane-wracked medical supply chain with wartime powers, drug compounding guidance
Editor's Note The Biden administration has invoked wartime powers to speed rebuilding of intravenous fluid (IV) manufacturing capacity, CBS News reported October 15, four days after the US Food and Drug Administration (FDA) took steps to combat drug shortages. Both efforts are in response to devastation wrought by Hurricane Helene,…
FDA approves single-dose propofol amid drug shortage
Editor's Note The Food and Drug Administration (FDA) approved Amneal Pharmaceuticals' Abbreviated New Drug Application for single-dose vials of propofol injectable emulsion, Anesthesiology News August 23 reports. The newly approved formulations include 200 mg/20 mL, 500 mg/50 mL, and 1,000 mg/100 mL vials. Propofol is widely used for anesthesia and…
Unveiling ECRI’s 2024 top 10 health technology hazards list
What is the purpose of the top 10 health technology hazards list, released every year by ECRI? “Our number one goal at ECRI is to reduce preventable harm,” stresses Jason Launders, MSC, former director of operations, device evaluation, at ECRI. “We know that every healthcare provider has a lot they…
FDA: Class I recall of Baxter’s Abacus software app
Editor's Note The Food and Drug Administration (FDA) on July 25 identified the recall by Baxter Healthcare Corporation of its Abacus Order Entry and Calculation Software application as Class I, the most serious. The Abacus software app can translate a physician’s order into a compounded solution. The recall was initiated…
Free Daily News
- Large-scale studies link preoperative cognition to delirium risk, reveal its deadly toll after surgery
- Socioeconomic deprivation linked to lower fitness before surgery, UK study finds
- Perioperative medication decisions need individualized risk-benefit approach
- FDA: National IV saline shortage over after years of strained supply
- FDA announces Class 1 recall for Draeger breathing filters
- Hospital CEO departures surge, boards turn to interim leadership
- Study: Attire shapes patient trust, perceptions
- ASC drill success hinges on preparation, adaptability, clear roles
- Robotic surgery shows better outcomes in select emergency colorectal cases, poised for wider use
- 5 costly mistakes to avoid when building an ASC